313 related articles for article (PubMed ID: 20302635)
1. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
[TBL] [Abstract][Full Text] [Related]
2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
3. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract][Full Text] [Related]
4. Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
Venkatesan N; Kanwar J; Deepa PR; Khetan V; Crowley TM; Raguraman R; Sugneswari G; Rishi P; Natarajan V; Biswas J; Krishnakumar S
PLoS One; 2016; 11(1):e0146128. PubMed ID: 26812476
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.
Glud M; Klausen M; Gniadecki R; Rossing M; Hastrup N; Nielsen FC; Drzewiecki KT
J Invest Dermatol; 2009 May; 129(5):1219-24. PubMed ID: 19005486
[TBL] [Abstract][Full Text] [Related]
6. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
8. Differences in microRNA expression between melanoma and healthy adjacent skin.
Aksenenko M; Palkina N; Komina A; Tashireva L; Ruksha T
BMC Dermatol; 2019 Jan; 19(1):1. PubMed ID: 30611259
[TBL] [Abstract][Full Text] [Related]
9. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
[TBL] [Abstract][Full Text] [Related]
10. Quantification of microRNA-21 and microRNA-125b in melanoma tissue.
Wandler A; Riber-Hansen R; Hager H; Hamilton-Dutoit SJ; Schmidt H; Nielsen BS; Stougaard M; Steiniche T
Melanoma Res; 2017 Oct; 27(5):417-428. PubMed ID: 28614272
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
[TBL] [Abstract][Full Text] [Related]
13. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
15. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.
Nurul-Syakima AM; Yoke-Kqueen C; Sabariah AR; Shiran MS; Singh A; Learn-Han L
Int J Mol Med; 2011 Sep; 28(3):327-36. PubMed ID: 21637912
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA signatures in hereditary breast cancer.
Murria Estal R; Palanca Suela S; de Juan Jiménez I; Egoavil Rojas C; García-Casado Z; Juan Fita MJ; Sánchez Heras AB; Segura Huerta A; Chirivella González I; Sánchez-Izquierdo D; Llop García M; Barragán González E; Bolufer Gilabert P
Breast Cancer Res Treat; 2013 Nov; 142(1):19-30. PubMed ID: 24129975
[TBL] [Abstract][Full Text] [Related]
18. Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.
DiVincenzo MJ; Latchana N; Abrams Z; Moufawad M; Regan-Fendt K; Courtney NB; Howard JH; Gru AA; Zhang X; Fadda P; Carson WE
Melanoma Res; 2020 Oct; 30(5):455-464. PubMed ID: 32804708
[TBL] [Abstract][Full Text] [Related]
19. microRNA-10b is a prognostic biomarker for melanoma.
Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
[TBL] [Abstract][Full Text] [Related]
20. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]